We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVA icon
3076
Innoviva
INVA
$1.55B
$781K ﹤0.01%
74,159
+29,504
+66% +$353K
EZU icon
3077
iShare MSCI Eurozone ETF
EZU
$9.64B
$780K ﹤0.01%
20,061
-382,644
-95% -$14.8M
KOS icon
3078
CALL
Kosmos Energy
KOS
$1.6B
$780K ﹤0.01%
+125,000
New +$768K
RDUS
3079
DELISTED
Radius Recycling
RDUS
$780K ﹤0.01%
37,754
+8,990
+31% +$217K
TSEM icon
3080
Tower Semiconductor
TSEM
$24.8B
$780K ﹤0.01%
40,539
+3,794
+10% +$70.8K
PWB icon
3081
Invesco Large Cap Growth ETF
PWB
$2.29B
$777K ﹤0.01%
16,079
+8,206
+104% +$402K
WLH
3082
DELISTED
WILLIAM LYON HOMES
WLH
$777K ﹤0.01%
38,195
+2,503
+7% +$46.8K
AGM icon
3083
Federal Agricultural Mortgage
AGM
$2.47B
$776K ﹤0.01%
9,500
+1,038
+12% +$81.5K
THR
3084
DELISTED
Thermon Group Holdings
THR
$776K ﹤0.01%
33,774
+4,683
+16% +$111K
AABA
3085
PUT
DELISTED
Altaba Inc
AABA
$775K ﹤0.01%
39,800
-900
-2% -$59.5K
FDL icon
3086
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.74B
$774K ﹤0.01%
24,930
+16,309
+189% +$498K
AMPH icon
3087
Amphastar Pharmaceuticals
AMPH
$879M
$772K ﹤0.01%
38,978
+9,306
+31% +$194K
RGS icon
3088
Regis Corp
RGS
$68.4M
$772K ﹤0.01%
1,910
+299
+19% +$107K
OMP
3089
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$772K ﹤0.01%
48,338
+38,986
+417% +$709K
APOG icon
3090
Apogee Enterprises
APOG
$826M
$771K ﹤0.01%
19,770
+3,447
+21% +$136K
ATRC icon
3091
AtriCure
ATRC
$1.92B
$771K ﹤0.01%
30,960
+1,611
+5% +$46K
SSO icon
3092
ProShares Ultra S&P500
SSO
$7.87B
$771K ﹤0.01%
48,000
SUZ icon
3093
Suzano
SUZ
$10.5B
$769K ﹤0.01%
+95,356
New +$756K
TW icon
3094
PUT
Tradeweb Markets
TW
$21.4B
$769K ﹤0.01%
+20,800
New +$919K
KRO icon
3095
KRONOS Worldwide
KRO
$693M
$767K ﹤0.01%
61,953
-79,988
-56% -$992K
CIR
3096
DELISTED
CIRCOR International, Inc
CIR
$766K ﹤0.01%
20,421
-24,793
-55% -$943K
FOSL icon
3097
PUT
Fossil Group
FOSL
$293M
$764K ﹤0.01%
61,100
LVGO
3098
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$764K ﹤0.01%
+43,823
New +$1.33M
ALTR
3099
DELISTED
Altair Engineering Inc
ALTR
$761K ﹤0.01%
21,968
-1,030
-4% -$38.4K
SPPI
3100
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$760K ﹤0.01%
91,677
+13,898
+18% +$112K

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.